Transplants
Brazil's Fiocruz, through its Farmanguinhos unit, has begun fully domestic production of tacrolimus, an immunosuppressant to prevent organ transplant rejection. The milestone stems from a Product Development Partnership (PDP) with Brazilian firm Libbs, which acquired manufacturing technology from India's Biocon. Farmanguinhos now becomes the sole supplier to the SUS public health system.
An Ruwaito ta hanyar AI
The Gregorio Marañón University Hospital has successfully performed Europe's first partial heart transplant on a seven-month-old baby. Mariami is recovering well after leaving Intensive Care just two days post-surgery. This breakthrough, endorsed by transplant authorities, combines pioneering techniques and could transform treatments for children with heart defects.